Neogen (NASDAQ:NEOG) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Neogen (NASDAQ:NEOG) announced its quarterly earnings data on Thursday. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03), Briefing.com reports. The business had revenue of $217.00 million during the quarter, compared to analyst estimates of $215.05 million. Neogen had a negative net margin of 1.02% and a positive return on equity of 3.09%. The company’s revenue for the quarter was down 5.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.11 EPS. Neogen updated its FY 2025 guidance to EPS.

Neogen Trading Up 4.6 %

NASDAQ NEOG opened at $14.43 on Friday. The stock has a market capitalization of $3.13 billion, a PE ratio of -360.75 and a beta of 1.21. The firm has a 50 day moving average of $16.22 and a two-hundred day moving average of $15.19. Neogen has a 52 week low of $11.46 and a 52 week high of $20.89. The company has a quick ratio of 2.59, a current ratio of 3.82 and a debt-to-equity ratio of 0.28.

Insider Buying and Selling

In other Neogen news, Director James P. Tobin purchased 3,000 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was bought at an average cost of $16.86 per share, with a total value of $50,580.00. Following the acquisition, the director now directly owns 23,392 shares of the company’s stock, valued at approximately $394,389.12. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.13% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. StockNews.com upgraded shares of Neogen to a “sell” rating in a research note on Monday, September 30th. Piper Sandler boosted their target price on Neogen from $17.00 to $17.50 and gave the stock a “neutral” rating in a research note on Tuesday, August 6th.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.